|
Harvard University fund sells all Israel holdings
In another blow to Israeli shares, the Harvard Management Company notified the US Securities and Exchange Commission (SEC) on Friday that it had sold all its holdings in Israeli companies during the second quarter of 2010. No reason for the sale was mentioned. The Harvard Management Company manages Harvard University's endowment. Chickens. Harvard Management Company stated in its 13-F Form that it sold 483,590 shares in Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) for $30.5 million; 52,360 shares in NICE Systems Ltd. (Nasdaq: NICE; TASE: NICE) for $1.67 million; 102,940 shares in Check Point Software Technologies Ltd. (Nasdaq: CHKP) for $3.6 million; 32,400 shares in Cellcom Israel Ltd. (NYSE:CEL; TASE:CEL) for $1.1 million, and 80,000 Partner Communications Ltd. (Nasdaq: PTNR; TASE: PTNR) shares for $1.8 million. Harvard Management Company's 13-F Form shows some interesting investments. Its two largest holdings, each worth $295 million, are in iShares ETFs, one on Chinese equities, and the other on emerging markets. Harvard also owns $181 million in a Brazilian ETF. Some thoughts: 1) Concerns about Israel's existance in the future. 2) Liberal ideas of the need to "punish" Israel for defending itself. 3) Both. I don't know the political makeup of those who run Harvard's investments. I suspect #1 myself because I know enough about Teva to be able to say it kicks butt, and has/is coming out with one-of-a-kind drugs. Posted by: gorb 2010-08-16 |
| http://www.rantburg.com/poparticle.php?ID=303476 |